Free Trial

Smith & Nephew (SN) Competitors

Smith & Nephew logo
GBX 1,120.50 +2.50 (+0.22%)
As of 06/11/2025

SN vs. HLN, SGE, WHR, ANP, CLX, TPX, PNPL, LEG, ULVR, and NIOX

Should you be buying Smith & Nephew stock or one of its competitors? The main competitors of Smith & Nephew include Haleon (HLN), The Sage Group (SGE), Warehouse REIT (WHR), Anpario (ANP), Calnex Solutions (CLX), TPXimpact (TPX), Pineapple Power (PNPL), Legendary Investments (LEG), Unilever (ULVR), and NIOX Group (NIOX).

Smith & Nephew vs. Its Competitors

Smith & Nephew (LON:SN) and Haleon (LON:HLN) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

Haleon has a net margin of 9.66% compared to Smith & Nephew's net margin of 5.41%. Haleon's return on equity of 6.54% beat Smith & Nephew's return on equity.

Company Net Margins Return on Equity Return on Assets
Smith & Nephew5.41% 5.85% 4.51%
Haleon 9.66%6.54%4.45%

62.2% of Smith & Nephew shares are owned by institutional investors. Comparatively, 43.9% of Haleon shares are owned by institutional investors. 0.2% of Smith & Nephew shares are owned by insiders. Comparatively, 10.7% of Haleon shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Smith & Nephew received 548 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 62.02% of users gave Smith & Nephew an outperform vote while only 31.58% of users gave Haleon an outperform vote.

CompanyUnderperformOutperform
Smith & NephewOutperform Votes
560
62.02%
Underperform Votes
343
37.98%
HaleonOutperform Votes
12
31.58%
Underperform Votes
26
68.42%

Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.6%. Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.5%. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Haleon pays out 50.5% of its earnings in the form of a dividend.

Haleon has higher revenue and earnings than Smith & Nephew. Haleon is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smith & Nephew£7.08B1.73£382.79M£27.7740.34
Haleon£11.07B3.26£1.07B£11.8933.66

Smith & Nephew has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, Haleon has a beta of 0.19, indicating that its share price is 81% less volatile than the S&P 500.

In the previous week, Smith & Nephew and Smith & Nephew both had 1 articles in the media. Smith & Nephew's average media sentiment score of 1.16 beat Haleon's score of 0.00 indicating that Smith & Nephew is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Smith & Nephew
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Haleon
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Smith & Nephew currently has a consensus target price of GBX 7,840, indicating a potential upside of 599.69%. Haleon has a consensus target price of GBX 457, indicating a potential upside of 14.19%. Given Smith & Nephew's higher possible upside, analysts clearly believe Smith & Nephew is more favorable than Haleon.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smith & Nephew
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Haleon
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Smith & Nephew beats Haleon on 11 of the 18 factors compared between the two stocks.

Get Smith & Nephew News Delivered to You Automatically

Sign up to receive the latest news and ratings for SN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SN vs. The Competition

MetricSmith & NephewMedical Devices IndustryMedical SectorLON Exchange
Market Cap£12.28B£3.30B£5.60B£2.93B
Dividend Yield3.66%2.44%5.28%4.90%
P/E Ratio40.3473.4227.23123.18
Price / Sales1.73112.47417.65243,308.49
Price / Cash18.6815.9938.2528.07
Price / Book1.883.817.124.75
Net Income£382.79M£126.02M£3.23B£5.91B
7 Day Performance3.51%1.35%2.74%6.94%
1 Month Performance4.82%9.78%8.94%16.69%
1 Year Performance11.11%-0.49%31.59%77.68%

Smith & Nephew Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SN
Smith & Nephew
4.0326 of 5 stars
GBX 1,120.50
+0.2%
GBX 7,840
+599.7%
+8.9%£12.28B£7.08B40.3418,452News Coverage
Positive News
High Trading Volume
HLN
Haleon
1.3001 of 5 stars
GBX 414.70
+0.1%
GBX 457
+10.2%
+24.4%£37.43B£11.07B34.8825,408High Trading Volume
SGE
The Sage Group
2.2178 of 5 stars
GBX 1,232.50
+1.1%
GBX 3,446.67
+179.6%
+21.6%£12.20B£2.14B47.9111,326Dividend Increase
WHR
Warehouse REIT
1.8923 of 5 stars
GBX 106.20
+0.2%
GBX 108
+1.7%
+32.8%£449.88M£50.81M1.0361,000News Coverage
Earnings Report
ANP
Anpario
N/AGBX 436.26
-2.0%
GBX 435
-0.3%
+42.0%£74.43M£33.50M24.09109
CLX
Calnex Solutions
3.2632 of 5 stars
GBX 54.26
-1.3%
GBX 115
+111.9%
+7.0%£48.22M£16.52M1,200.459,000News Coverage
Insider Trade
Gap Up
TPX
TPXimpact
N/AGBX 23.30
+3.6%
N/A-50.6%£21.15M£84.64M-1.0312,000Gap Up
PNPL
Pineapple Power
N/AN/AN/AN/A£2.28MN/A-274.002High Trading Volume
LEG
Legendary Investments
N/AN/AN/AN/A£0.00N/A0.0019,900Gap Down
ULVR
Unilever
0.6726 of 5 stars
GBX 4,652
+0.0%
GBX 4,000
-14.0%
+6.4%£137.38B£70.72B21.04148,000High Trading Volume
NIOX
NIOX Group
N/AGBX 69
+1.2%
GBX 90
+30.4%
+0.0%£28.34B£3.53B2,847.5192

Related Companies and Tools


This page (LON:SN) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners